Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 15, 2023 08:44 ET | Source: Johnson Fistel, LLP

Veritiv Corporation (VRTV) News: Johnson Fistel Investigates Proposed Sale of Veritiv Corporation; Is $170.00 a Fair Price?

SAN DIEGO, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Veritiv Corporation ("Veritiv" or the...
February 27, 2023 12:25 ET | Source: Wohl & Fruchter LLP

FOCS Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Sale of Focus Financial Partners to Clayton, Dubilier & Rice

MONSEY, N.Y., Feb. 27, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of Focus Financial Partners, Inc. (Nasdaq: FOCS) (“Focus”) acted in...
November 10, 2020 08:00 ET | Source: Core & Main

Core & Main Elects Orv Kimbrough to Board

St. Louis, Nov. 10, 2020 (GLOBE NEWSWIRE) -- Core & Main LP, a leading U.S. distributor of water, sewer and fire protection products, has elected Orv Kimbrough to its board. Kimbrough serves as...
December 30, 2019 23:30 ET | Source: Rigrodsky & Long, P.A.

Rigrodsky & Long, P.A. Files Class Action Suit Against Anixter International Inc.

WILMINGTON, Del., Dec. 30, 2019 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.: Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court...
December 18, 2018 11:21 ET | Source: Silverline

Silverline Teams up with Clayton to Deliver Long-Term Success to Customers

New York City, NY, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Silverline, a Salesforce Platinum Cloud Alliance Partner headquartered in New York City announced today a strategic partnership with Clayton, the...
June 17, 2018 20:06 ET | Source: Telix Pharmaceuticals Limited

Science and Industry Endowment Fund Grant Awarded for Advanced Biologics Manufacturing

MELBOURNE, Australia, June 18, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of...